Hypha will be exhibiting at the EFMC-ISMC 2022 conference (XXVll EFMC International Symposium on Medicinal Chemistry) being held in Nice, France on 4-8 September. Come and meet Frank and Sam at booth 16.
About EFMC-ISMC 2022
The 2022 programme will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, neurodegenerative and cardiovascular diseases, rare diseases and cancer. The conference will also feature the most recent advances in new technologies such as the exploitation of RNA as drug target, artificial intelligence in drug discovery, natural products-based drug discovery, DNA encoded libraries applications and the development of covalent drugs, PROTACs and molecular glues. Innovative approaches in medicinal chemistry will be included such as the development of immunomodulating compounds or the application of affinity selection – mass spectrometry for drug discovery. In a series of dedicated sessions, the interface between chemical biology and drug discovery will be highlighted, including topics such as in vivo chemistry for target discovery and validation, molecular imaging, and photochemical approaches.